Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Financial Analysts Upgrade Price Target for Plains All American Pipeline

Elaine Mendonca by Elaine Mendonca
March 2, 2024
in Breaking News
0
Wind Farms: How Strategic Acquisitions Amplify the Impact of Green Energy Players
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

On March 2, 2024, financial analyst Spiro Dounis of Citigroup decided to maintain Plains All American (NYSE:PAA) with a Neutral rating but increased the price target to $17.5. This adjustment came after Citigroup upgraded the stock, setting a new 52-week high for Plains All American Pipeline. In addition, TD Securities also raised their target price on PAA from $16.00 to $17.00, giving it a “buy” rating. The average price target for Plains All American is now $16.56, with a high forecast of $17.50.

Plains All American Pipeline, L.P. (PAA) Shows Strong Performance in Stock Market on March 2, 2024

On March 2, 2024, Plains All American Pipeline, L.P. (PAA) exhibited strong performance in the stock market. PAA was trading near the top of its 52-week range and above its 200-day simple moving average, indicating positive momentum for the stock. The price of PAA shares experienced a notable increase of $0.17 since the market closed, representing a 1.04% rise in value. The stock closed at $16.59, reflecting the positive sentiment among investors. In after-hours trading, PAA saw a slight decline in its stock price, dropping $0.35. Overall, the performance of PAA on March 2, 2024, suggests that the stock has been experiencing positive momentum and investor interest. Investors should continue to monitor PAA’s performance and market trends to make informed decisions about their investments.

Plains All American Pipeline (PAA) Stock Analysis: Revenue, Net Income, and EPS Show Positive Growth Trends

On March 2, 2024, Plains All American Pipeline (PAA) stock showed promising performances based on the financial data provided. The company’s total revenue for the past year was $48.74 billion, with a quarterly revenue of $12.71 billion. Despite a 14.64% decrease in total revenue compared to the previous year, there was a 4.04% increase in revenue since the last quarter.

Plains All American Pipeline reported a net income of $1.23 billion for the year and $311.00 million for the fourth quarter. This represents an 18.7% increase in net income compared to the previous year and a significant 53.2% increase since the last quarter.

In terms of earnings per share (EPS), PAA reported $1.40 for the year and $0.35 for the fourth quarter. The EPS increased by 17.79% since the previous year and a remarkable 76.9% since the last quarter.

These financial indicators suggest that Plains All American Pipeline has been able to improve its profitability and financial performance in the recent quarter. Investors may find these positive trends in revenue, net income, and EPS as encouraging signs for the company’s future growth potential.

Tags: PAA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finances-and-tech

Bright Future Ahead for R1 RCM Analysts Predict 4694 Upside Potential

Everi Holdings Faces Stock Decline After Downgrades from Jefferies and Truist Securities

Finances-and-tech

NCR Voyix Faces Stock Market Turbulence After Unveiling Preliminary Financial Results

Recommended

Upcoming FDA Advisory Committee Meeting for Imetelstat A Groundbreaking Treatment for Malignant Stem Cells

2 years ago
Portillo's Stock

Leadership Turmoil Sends Portillo’s Shares to New Low

2 months ago
Dine Brands Global Stock

Dine Brands Stock Faces Potential Downturn

1 month ago
Intel Stock

US Government Considers Taking Equity Stake in Intel

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Procter & Gamble Shares Approach a Critical Juncture

Trending

XRP Stock
Analysis

XRP Market Dynamics: Institutional Pause Meets Accumulation Surge

by Andreas Sommer
January 11, 2026
0

The XRP market is currently defined by a stark divergence in investor behavior. After a powerful rally...

Rocket Lab USA Stock

Rocket Lab’s Stock Momentum Continues Unabated in 2026

January 11, 2026
Eli Lilly Stock

Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

January 11, 2026
Alibaba Stock

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

January 11, 2026
Vulcan Energy Stock

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • XRP Market Dynamics: Institutional Pause Meets Accumulation Surge
  • Rocket Lab’s Stock Momentum Continues Unabated in 2026
  • Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com